TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Novabridge Biosciences
NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward

NovaBridge's subsidiary Visara appointed Dr. Cadmus C. Rich as Chief Medical Officer and Dr. Carlos Quezada-Ruiz as Scientific Advisory Board Chair to advance VIS-101, a novel bifunctional biologic targeting VEGF-A/ANG2 for treating retinal diseases.

Insights
BL   neutral

Mentioned as a top holding with no detailed performance context


NBP   positive

Company is expanding leadership team with experienced professionals and advancing promising drug candidate VIS-101